The contribution of inhibitory interneurons to circuit dysfunction in Fragile X Syndrome
Open accessThe DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
Many neurological disorders, including neurodevelopmental disorders, report hypersynchrony of neuronal networks. These alterations in neuronal synchronization suggest a link to the function of inhibitory interneurons. In Fragile X Syndrome (FXS), it has been reported that altered synchronization may underlie hyperexcitability, cognitive dysfunction and provide a link to the increased incidence of epileptic seizures. Therefore, understanding the roles of inhibitory interneurons and how they control neuronal networks is of great importance in studying neurodevelopmental disorders such as FXS. Here, we present a review of how interneuron populations and inhibition are important contributors to the loss of excitatory/inhibitory balance seen in hypersynchronous and hyperexcitable networks from neurodevelopmental disorders, and specifically in FXS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Verkerk, A. J. M. H., Pieretti, M., Sutcliffe, J. S., Fu, Y.-H., Kuhl, D. P. A., Pizzuti, A., Reiner, O., Richards, S., Victoria, M. F., Zhang, F., et al. (1991) · Cell · doi:10.1016/0092-8674(91)90397-h · Cited by 3,481 · cited 1×
“Since the FMR1 gene was first identified and linked to FXS in 1991 (Verkerk et al., 1991), tremendous progress has been made to understand the neurological deficits that contribute to the phenotype.”
BackgroundInterneurons of the neocortical inhibitory system
Markram, H., Toledo-Rodriguez, M., Wang, Y., Gupta, A., Silberberg, G., & Wu, C. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1519 · Cited by 2,954 · cited 2×
“role(s) played by this large and heterogeneous cell population (Buzsáki et al., 1992; Gulyás et al., 1993a,b; Buhl et al., 1994; Miles et al., 1996; Gupta et al., 2000; Markram et al., 2004).”
BackgroundNeuronal Diversity and Temporal Dynamics: The Unity of Hippocampal Circuit Operations
Klausberger, T., & Somogyi, P. (2008) · Science · doi:10.1126/science.1149381 · Cited by 2,050
The mGluR theory of fragile X mental retardation
Bear, M. F., Huber, K. M., & Warren, S. T. (2004) · Trends in Neurosciences · doi:10.1016/j.tins.2004.04.009 · Cited by 1,580 · cited 3×
“…these profound changes include alterations in both excitatory and inhibitory neurotransmission across multiple brain regions (Huber et al., 2002; Bear et al., 2004; Bureau et al., 2008; Harlow et al., 2010; Olmos-Serrano et al., 2010; Till et al., 2012; Van der Molen et al., 2012; Kim et al.,…”
BackgroundSynchronization of neuronal activity in hippocampus by individual GABAergic interneurons
Cobb, S. R., Buhl, E. H., Halasy, K., Paulsen, O., & Somogyi, P. (1995) · Nature · doi:10.1038/378075a0 · Cited by 1,498 · cited 1×
“Their physiological properties and connectivity allow them to control the rhythmic output of large populations of excitatory principal cells as well as other populations of inhibitory interneurons (Cobb et al., 1995; Freund and Katona, 2007; Klausberger and Somogyi, 2008).”
BackgroundAltered synaptic plasticity in a mouse model of fragile X mental retardation
Huber, K. M., Gallagher, S. M., Warren, S. T., & Bear, M. F. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.122205699 · Cited by 1,349 · cited 5×
“CELLULAR NEUROSCIENCE REVIEW ARTICLE published: 25 August 2014 doi: 10.3389/fncel.2014.00245 The contribution of inhibitory interneurons to circuit dysfunction in Fragile X Syndrome”
BackgroundInfluentialBrain-state- and cell-type-specific firing of hippocampal interneurons in vivo
Klausberger, T., Magill, P. J., Márton, L. F., Roberts, J. D. B., Cobden, P. M., Buzsáki, G., & Somogyi, P. (2003) · Nature · doi:10.1038/nature01374 · Cited by 1,345 · cited 1×
“…excitation of fast-spiking (FS) inhibitory interneurons, a perisomatic-targeting interneuron that engage preferably in frequencies between 40–100 Hz (Klausberger et al., 2003), is robustly decreased in neocortex in Fmr1 KO mice (Selby et al., 2007; Patel et al., 2013), which could explain the…”
BackgroundBrown, V., Jin, P., Ceman, S., Darnell, J. C., O'Donnell, W. T., Tenenbaum, S. A., Jin, X., Feng, Y., Wilkinson, K. D., Keene, J. D., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00568-2 · Cited by 1,109 · cited 1×
“The loss of this protein is far reaching because FMRP interacts with approximately 4–8% of all synaptic mRNAs and regulates the translation of numerous synaptic proteins and receptor systems (Brown et al., 2001).”
BackgroundOrganizing principles for a diversity of GABAergic interneurons and synapses in the neocortex
Gupta, A., Wang, Y., & Markram, H. (2000) · Science · doi:10.1126/science.287.5451.273 · Cited by 1,036
Correction of Fragile X Syndrome in Mice
Dölen, G., Osterweil, E., Rao, B. S. S., Smith, G. B., Auerbach, B. D., Chattarji, S., & Bear, M. F. (2007) · Neuron · doi:10.1016/j.neuron.2007.12.001 · Cited by 979
Differences between somatic and dendritic inhibition in the hippocampus
Miles, R., Tóth, K., Gulyás, A. I., Hájos, N., & Freund, T. F. (1996) · Neuron · doi:10.1016/s0896-6273(00)80101-4 · Cited by 942
Buhl, E. H., Halasy, K., & Somogyi, P. (1994) · Nature · doi:10.1038/368823a0 · Cited by 728 · cited 2×
“role(s) played by this large and heterogeneous cell population (Buzsáki et al., 1992; Gulyás et al., 1993a,b; Buhl et al., 1994; Miles et al., 1996; Gupta et al., 2000; Markram et al., 2004).”
BackgroundPostnatal neurodevelopmental disorders: meeting at the synapse?
Zoghbi, H. Y. (2003) · Science · doi:10.1126/science.1089071 · Cited by 691
Activity-dependent neuronal signalling and autism spectrum disorder
Ebert, D. H., & Greenberg, M. E. (2013) · Nature · doi:10.1038/nature11860 · Cited by 666
Freund, T. F., & Katona, I. (2007) · Neuron · doi:10.1016/j.neuron.2007.09.012 · Cited by 656
Advances in the Treatment of Fragile X Syndrome
Hagerman, R. J., Berry-Kravis, E., Kaufmann, W. E., Ono, M. Y., Tartaglia, N., Lachiewicz, A., Kronk, R., Delahunty, C., Hessl, D., Visootsak, J., et al. (2009) · Pediatrics · doi:10.1542/peds.2008-0317 · Cited by 596
Gibson, J. R., Bartley, A. F., Hays, S. A., & Huber, K. M. (2008) · Journal of Neurophysiology · doi:10.1152/jn.90752.2008 · Cited by 529 · cited 12×
“It is also reported that unitary IPSC amplitude mediated by LTS interneurons is increased in somatosensory cortex of Fmr1 KO mice (Gibson et al., 2008).”
BackgroundInfluentialSuppression of two major Fragile X Syndrome mouse model phenotypes by the mGluR5 antagonist MPEP
Yan, Q. J., Rammal, M., Tranfaglia, M., & Bauchwitz, R. P. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.06.004 · Cited by 521 · cited 1×
“…of 2-methyl-6-(phenylethynyl)pyridine (MPEP), fenobam and 2-chloro-4-((2,5-dimethyl-1-(4-(trifluoromethoxy) phenyl)-1H-imidazol-4-yl)ethynyl)pyridine (CTEP), the use of mGluR5 antagonists remains a primary treatment option for FXS (Porter et al., 2005; Yan et al., 2005; Lindemann et al., 2011).”
BackgroundChronic Pharmacological mGlu5 Inhibition Corrects Fragile X in Adult Mice
Michalon, A., Sidorov, M., Ballard, T. M., Ozmen, L., Spooren, W., Wettstein, J. G., Jaeschke, G., Bear, M. F., & Lindemann, L. (2012) · Neuron · doi:10.1016/j.neuron.2012.03.009 · Cited by 489
Incidence of Fragile X Syndrome by Newborn Screening for Methylated FMR1 DNA
Coffee, B., Keith, K., Albizua, I., Malone, T., Mowrey, J., Sherman, S. L., & Warren, S. T. (2009) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2009.09.007 · Cited by 436 · cited 1×
“Because of its association to the X chromosome, FXS has a higher prevalence in males as approximately of 1 in 3600–4000, than females (approximately 1 in 4000– 6000) (Coffee et al., 2009).”
BackgroundThe Pathophysiology of Fragile X Syndrome
Penagarikano, O., Mulle, J. G., & Warren, S. T. (2007) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.8.080706.092249 · Cited by 420 · cited 2×
“CELLULAR NEUROSCIENCE REVIEW ARTICLE published: 25 August 2014 doi: 10.3389/fncel.2014.00245 The contribution of inhibitory interneurons to circuit dysfunction in Fragile X Syndrome”
BackgroundInfluentialHippocampal pyramidal cells excite inhibitory neurons through a single release site
Gulyás, A. I., Miles, R., Sik, A., Tóth, K., Tamamaki, N., & Freund, T. F. (1993) · Nature · doi:10.1038/366683a0 · Cited by 384
Delayed Stabilization of Dendritic Spines in Fragile X Mice
Cruz-Martin, A., Crespo, M., & Portera-Cailliau, C. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.0577-10.2010 · Cited by 321
Decreased expression of the GABAA receptor in fragile X syndrome
D'Hulst, C., De Geest, N., Reeve, S. P., Van Dam, D., De Deyn, P. P., Hassan, B. A., & Kooy, R. F. (2006) · Brain Research · doi:10.1016/j.brainres.2006.08.115 · Cited by 318 · cited 2×
“, 2013), most other studies suggest the contrary, showing that mRNA expression of α1, α3 and α4β1 and β2, and γ1 and γ2, and δ GABAA receptor subunits in the hippocampus (D’Hulst et al., 2006) and the δ subunit in neocortex (Gantois et al.”
ResultBlatow, M., Rozov, A., Katona, I., Hormuzdi, S. G., Meyer, A. H., Whittington, M. A., Caputi, A., & Monyer, H. (2003) · Neuron · doi:10.1016/s0896-6273(03)00300-3 · Cited by 316
Olmos-Serrano, J. L., Paluszkiewicz, S. M., Martin, B. S., Kaufmann, W. E., Corbin, J. G., & Huntsman, M. M. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.1714-10.2010 · Cited by 309
Self-citationPorter, R. H. P., Jaeschke, G., Spooren, W., Ballard, T. M., Büttelmann, B., Kolczewski, S., Peters, J.-U., Prinssen, E., Wichmann, J., Vieira, E., et al. (2005) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.089839 · Cited by 308
Circuit level defects in the developing neocortex of fragile X mice
Gonçalves, J. T., Anstey, J. E., Golshani, P., & Portera-Cailliau, C. (2013) · Nature Neuroscience · doi:10.1038/nn.3415 · Cited by 279
Fanselow, E. E., Richardson, K. A., & Connors, B. W. (2008) · Journal of Neurophysiology · doi:10.1152/jn.90691.2008 · Cited by 262 · cited 2×
“Moreover, on a network level, LTS interneurons engage in theta frequency activity during mGluR activation (Fanselow et al., 2008; Bostrom et al., 2013) which would explain elevated theta power in EEG from FXS patients (Van der Molen and Van der Molen, 2013).”
BackgroundCritical period plasticity is disrupted in the barrel cortex of FMR1 knockout mice
Harlow, E. G., Till, S. M., Russell, T. A., Wijetunge, L. S., Kind, P., & Contractor, A. (2010) · Neuron · doi:10.1016/j.neuron.2010.01.024 · Cited by 252 · cited 3×
“CELLULAR NEUROSCIENCE REVIEW ARTICLE published: 25 August 2014 doi: 10.3389/fncel.2014.00245 The contribution of inhibitory interneurons to circuit dysfunction in Fragile X Syndrome”
BackgroundInfluentialDisrupted Homer scaffolds mediate abnormal mGluR5 function in a mouse model of fragile X syndrome
Ronesi, J. A., Collins, K. A., Hays, S. A., Tsai, N.-P., Guo, W., Birnbaum, S. G., Hu, J.-H., Worley, P. F., Gibson, J. R., & Huber, K. M. (2012) · Nature Neuroscience · doi:10.1038/nn.3033 · Cited by 251 · cited 1×
“…also reveal that pharmacological intervention of mGluR activation can rescue the FXS phenotype in the Fmr1 mouse model suggesting a therapeutic role for inhibitors of mGluR activityspecifically type 1 and type 5 receptor activity (Dölen et al., 2007; Michalon et al., 2012; Ronesi et al., 2012).”
BackgroundGulyás, A. I., Mlles, R., Hájos, N., & Freund, T. F. (1993) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1993.tb00240.x · Cited by 226
Distinct timing in the activity of cannabinoid-sensitive and cannabinoid-insensitive basket cells
Glickfeld, L. L., & Scanziani, M. (2006) · Nature Neuroscience · doi:10.1038/nn1688 · Cited by 222 · cited 2×
“…of different set of interneuron cell types in FXS neuronal network abnormalities, including basket cells and LTS cells in the cortex (Bacci et al., 2004; Lee et al., 2010) and basket cells and Schaffer collateral interneurons in the hippocampus (Glickfeld and Scanziani, 2006; Lee et al., 2010).”
BackgroundCircuit and Plasticity Defects in the Developing Somatosensory Cortex of Fmr1 Knock-Out Mice
Bureau, I., Shepherd, G. M. G., & Svoboda, K. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.1076-08.2008 · Cited by 201 · cited 4×
“, 2013), impaired critical plasticity periods for auditory, visual and somatosensory cortex also occurred in FXS (Bureau et al., 2008; Harlow et al., 2010; Till et al., 2012; Van der Molen et al., 2012; Kim et al., 2013).”
BackgroundInfluentialDual origins of functionally distinct O-LM interneurons revealed by differential 5-HT3AR expression
Chittajallu, R., Craig, M. T., McFarland, A., Yuan, X., Gerfen, S., Tricoire, L., Erkkila, B., Barron, S. C., Lopez, C. M., Liang, B. J., et al. (2013) · Nature Neuroscience · doi:10.1038/nn.3538 · Cited by 119
Lindemann, L., Jaeschke, G., Michalon, A., Vieira, E., Honer, M., Spooren, W., Porter, R., Hartung, T., Kolczewski, S., Büttelmann, B., et al. (2011) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.185660 · Cited by 118
Lee, S.-H., Foldy, C., & Soltesz, I. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.6238-09.2010 · Cited by 114
Cea-del Rio, C. A., Lawrence, J. J., Tricoire, L., Erdelyi, F., Szabo, G., & McBain, C. J. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.5040-09.2010 · Cited by 99 · cited 1×
“Inhibitory interneurons have differential response to neuromodulators, among them, acetylcholine muscarinic receptors (Cea-del Rio et al., 2010), nicotinic receptors (Bell et al., 2011), serotonin (Chittajallu et al., 2013) and endocannabinoids (eCB; Glickfeld and Scanziani, 2006; Lee et al., 2010).”
BackgroundAltered maturation of the primary somatosensory cortex in a mouse model of fragile X syndrome
Till, S. M., Wijetunge, L. S., Seidel, V. G., Harlow, E., Wright, A. K., Bagni, C., Contractor, A., Gillingwater, T. H., & Kind, P. C. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds030 · Cited by 91
Higashimori, H., Morel, L., Huth, J., Lindemann, L., Dulla, C., Taylor, A., Freeman, M., & Yang, Y. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt055 · Cited by 85
Secondary medical diagnosis in fragile X syndrome with and without autism spectrum disorder
García‐Nonell, C., Ratera, E. R., Harris, S., Hessl, D., Ono, M. Y., Tartaglia, N., Marvin, E., Tassone, F., & Hagerman, R. J. (2008) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.32290 · Cited by 76 · cited 1×
“The prevalence rate of autism in FXS reportedly ranges from 25% to 52% (Kaufmann et al., 2004; García-Nonell et al., 2008; Hall et al., 2008), often presenting ASD features such as social avoidance (Marco and Skuse, 2006).”
BackgroundBell, K. A., Shim, H., Chen, C.-K., & McQuiston, A. R. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.08.024 · Cited by 74 · cited 1×
“Inhibitory interneurons have differential response to neuromodulators, among them, acetylcholine muscarinic receptors (Cea-del Rio et al., 2010), nicotinic receptors (Bell et al., 2011), serotonin (Chittajallu et al., 2013) and endocannabinoids (eCB; Glickfeld and Scanziani, 2006; Lee et al., 2010).”
BackgroundImpaired Critical Period Plasticity in Primary Auditory Cortex of Fragile X Model Mice
Kim, H., Gibboni, R., Kirkhart, C., & Bao, S. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.3246-12.2013 · Cited by 74 · cited 3×
“CELLULAR NEUROSCIENCE REVIEW ARTICLE published: 25 August 2014 doi: 10.3389/fncel.2014.00245 The contribution of inhibitory interneurons to circuit dysfunction in Fragile X Syndrome”
BackgroundInfluential
Cited by
Excitation/Inhibition Imbalance in Animal Models of Autism Spectrum Disorders
Lee, E., Lee, J., & Kim, E. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2016.05.011 · Cited by 468
Steullet, P., Cabungcal, J.-H., Coyle, J., Didriksen, M., Gill, K., Grace, A. A., Hensch, T. K., LaMantia, A.-S., Lindemann, L., Maynard, T. M., et al. (2017) · Molecular Psychiatry · doi:10.1038/mp.2017.47 · Cited by 360
The GABAA Receptor as a Therapeutic Target for Neurodevelopmental Disorders
Braat, S., & Kooy, R. F. (2015) · Neuron · doi:10.1016/j.neuron.2015.03.042 · Cited by 294
Wang, J., Ethridge, L. E., Mosconi, M. W., White, S. P., Binder, D. K., Pedapati, E. V., Erickson, C. A., Byerly, M. J., & Sweeney, J. A. (2017) · Journal of Neurodevelopmental Disorders · doi:10.1186/s11689-017-9191-z · Cited by 176
“This enhanced gamma power is consistent with studies of fmr1 knockout mice demonstrating heightened neuronal excitability related to alterations in input to fast-spiking inhibitory interneurons that synchronize and control high-frequency gamma band neural activity [4, 40].”
Lazaro, M. T., Taxidis, J., Shuman, T., Bachmutsky, I., Ikrar, T., Santos, R., Marcello, G. M., Mylavarapu, A., Chandra, S., Foreman, A., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.05.006 · Cited by 125
Metadata
- Authors
- Cea-Del Rio, C. A., & Huntsman, M. M.
- Venue
- Frontiers in Cellular Neuroscience
- Publisher
- Frontiers Media SA
- Published
- 2014-08-25
- Volume
- 8
- Pages
- 245-245
- ISSN
- 1662-5102 (ISSN-L)
- OpenAlex
- W2051721197
- Cited by
- 68
- References
- 43
- FWCI
- 3.57
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.